A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
Main Authors: | Robert Schierwagen, Dipl.-Biol., Sabine Klein, PhD, Jonel Trebicka, MD, Phd |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X20300874 |
Similar Items
-
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01) -
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
by: Tilman Sauerbruch, et al.
Published: (2023-01-01) -
Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
by: Chiara Spiezia, et al.
Published: (2023-05-01) -
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
by: Matthias Kern, et al.
Published: (2012-01-01) -
Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
by: Lu Wang, et al.
Published: (2024-01-01)